The FDA issues final guidance on general wellness products, affirming that most will be exempt from any regulation.
The FDA has issued a crystal-clear guidance bearing on the immense proliferation of wellness devices and apps.
The New England Journal of Medicine carries a thoughtful article on FDA regulation of “mobile health” technologies.
Studies in the Journal of the American Medical Association look at the evidence behind FDA approval of new drugs and at the reasons for delay or denials of approval.
The Food and Drug Administration released its final guidance on mobile medical applications, a subject of intense concern for software developers and health technology companies.
IMS has a tremendous amount of information on prescription drug use and their reports are always worth paying attention to. The latest provides their outlook through 2016, finding steady increases in overall global spending, with less on brand names and more on generic.
Its March and spring nears; our Potpourri blooms with nuggets of health care information, including comparative regulation of medical devices in the US and Europe, do physicians always truthful with patients, CMS’ oversight of home health care agencies, the validity of a CMS’ measure of ER scanning, and patient-centered care.